医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Deep near infrared light-excited stable synergistic photodynamic and photothermal therapies based on P-IR890 nano-photosensitizer constructed via a non-cyanine dye

摘要The cyanine dyes represented by IR780 can achieve synergistic photodynamic therapy(PDT)and photothermal therapy(PTT)under the stimulation of near-infrared(NIR)light(commonly 808 nm).Unfortunately,the stability of NIR-excited cyanine dyes is not satisfactory.These cyanine dyes can be attacked by self-generated reactive oxygen species(ROS)during PDT processes,resulting in structural damage and rapid degradation,which is fatal for phototherapy.To address this issue,a novel non-cyanine dye(IR890)was elaborately designed and synthesized by our team.The maximum absorption wavelength of IR890 was located in the deep NIR region(ca.890 nm),which was beneficial for further improving tissue penetration depth.Importantly,IR890 exhibited good stability when continuously illuminated by deep NIR light.To improve the hydrophilicity and biocompatibility,the hydrophobic IR890 dye was grafted onto the side chain of hydrophilic polymer(POEGMA-b-PGMA-g-C≡CH)via click chemistry.Then,the synthesized POEGMA-b-PGMA-g-IR890 amphiphilic polymer was utilized to prepare P-IR890 nano-photosensitizer via self-assembly method.Under irradiation with deep NIR light(850 nm,0.5 W/cm2,10 min),the dye degradation rate of P-IR890 was less than 5%.However,IR780 was almost completely degraded with the same light output power density and irradiation duration.In addition,P-IR890 could stably generate a large number of ROS and heat at the same time.It was rarely reported that the stable synergistic combination therapy of PDT and PTT could be efficiently performed by a single photosensitizer via irradiation with deep NIR light.P-IR890 exhibited favorable anti-tumor outcomes through apoptosis pathway.Therefore,the P-IR890 could provide a new insight into the design of photosensitizers and new opportunities for synergistic combination therapy of PDT and PTT.

更多
广告
作者单位 Affiliated Cixi Hospital,Wenzhou Medical University,Ningbo 325300,China;Shanghai Key Laboratory of Functional Materials Chemistry,School of Materials Science and Engineering,East China University of Science and Technology,Shanghai 200237,China;School of Pharmaceutical Science,Wenzhou Medical University,Wenzhou 325000,China;Oujiang Laboratory,Zhejiang Lab for Regenerative Medicine,Vision and Brain Health,School of Pharmaceutical Science,Wenzhou 325000,China [1] Institute for Environmental Pollution and Health,School of Environmental and Chemical Engineering,Shanghai University,Shanghai 200444,China;Shanghai Key Laboratory of Chemical Biology,School of Pharmacy,East China University of Science and Technology,Shanghai 200237,China [2] Affiliated Cixi Hospital,Wenzhou Medical University,Ningbo 325300,China;School of Pharmaceutical Science,Wenzhou Medical University,Wenzhou 325000,China;Oujiang Laboratory,Zhejiang Lab for Regenerative Medicine,Vision and Brain Health,School of Pharmaceutical Science,Wenzhou 325000,China [3] Affiliated Cixi Hospital,Wenzhou Medical University,Ningbo 325300,China;School of Pharmaceutical Science,Wenzhou Medical University,Wenzhou 325000,China [4] School of Pharmaceutical Science,Wenzhou Medical University,Wenzhou 325000,China;Oujiang Laboratory,Zhejiang Lab for Regenerative Medicine,Vision and Brain Health,School of Pharmaceutical Science,Wenzhou 325000,China;Rehabilitation Medicine Center,The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,Wenzhou 325000,China [5] School of Pharmaceutical Science,Wenzhou Medical University,Wenzhou 325000,China;Oujiang Laboratory,Zhejiang Lab for Regenerative Medicine,Vision and Brain Health,School of Pharmaceutical Science,Wenzhou 325000,China;National Key laboratory of macromolecular drug development and manufacturing,School of Pharmaceutical Science,Wenzhou Medical University 325035,China [6] State Key Laboratory of Bioreactor Engineering,Biomedical Nanotechnology Center,Shanghai Collaborative Innovation Center for Biomanufacturing Technology,School of Biotechnology,East China University of Science and Technology,Shanghai 200237,China [7] Shanghai Key Laboratory of Functional Materials Chemistry,School of Materials Science and Engineering,East China University of Science and Technology,Shanghai 200237,China [8] Affiliated Cixi Hospital,Wenzhou Medical University,Ningbo 325300,China;School of Pharmaceutical Science,Wenzhou Medical University,Wenzhou 325000,China;Oujiang Laboratory,Zhejiang Lab for Regenerative Medicine,Vision and Brain Health,School of Pharmaceutical Science,Wenzhou 325000,China;National Key laboratory of macromolecular drug development and manufacturing,School of Pharmaceutical Science,Wenzhou Medical University 325035,China [9]
栏目名称
DOI 10.1016/j.ajps.2024.100955
发布时间 2025-01-09(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览0
  • 下载0
亚洲药物制剂科学(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷